130 related articles for article (PubMed ID: 1471917)
21. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
Cohn DE; Huh WK; Fowler JM; Straughn JM
Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic factors of endometrial carcinoma: a study of 98 cases].
Yin LJ
Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):150-2, 188. PubMed ID: 8354094
[TBL] [Abstract][Full Text] [Related]
23. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.
Morrow CP; Bundy BN; Kurman RJ; Creasman WT; Heller P; Homesley HD; Graham JE
Gynecol Oncol; 1991 Jan; 40(1):55-65. PubMed ID: 1989916
[TBL] [Abstract][Full Text] [Related]
24. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
25. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
Grénman SE; Klemi P; Toikkanen S; Irjala K; Laippala P; Vähä-Eskeli K; Mäenpää J; Salmi T
Ann Chir Gynaecol Suppl; 1994; 208():10-4. PubMed ID: 8092757
[TBL] [Abstract][Full Text] [Related]
26. Relations between various DNA-parameters and degree of malignancy in endometrial carcinoma.
Naumann G; Köhler U; Nenning H; Emmert C; Taubert G; Bilek K
Arch Gynecol Obstet; 1996; 258(3):113-7. PubMed ID: 8781698
[TBL] [Abstract][Full Text] [Related]
27. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
28. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
29. The role of preoperative brachytherapy as an adjunct to surgery and postoperative radiotherapy in the treatment of stage I endometrial carcinoma.
Póka R; Szluha K; Lampé L; Urbancsek H; Borsos A
Eur J Obstet Gynecol Reprod Biol; 2000 Oct; 92(2):241-9. PubMed ID: 10996689
[TBL] [Abstract][Full Text] [Related]
30. [Cervix uteri cancer: determination of DNA content by means of cytophotometry].
Wistuba I; Roa I; Villaseca MA; Araya JC; Capurro I
Rev Med Chil; 1993 Aug; 121(8):873-9. PubMed ID: 8296094
[TBL] [Abstract][Full Text] [Related]
31. [Long-term results of postoperative radiotherapy for stage I endometrial carcinoma].
Micke O; Bruns F; Halek G; Schäfer U; Schuck A; Willich N
Strahlenther Onkol; 2003 Nov; 179(11):729-36. PubMed ID: 14605741
[TBL] [Abstract][Full Text] [Related]
32. Rapid death following papillary serous carcinoma of the endometrium without myometrial invasion.
Suzuki M; Ohwada M; Kanai N; Sato I
Oncol Rep; 1999; 6(5):1009-12. PubMed ID: 10425295
[TBL] [Abstract][Full Text] [Related]
33. [Variability of quantitative DNA parameters in endometrial carcinoma].
Köhler U; Naumann G; Nenning A; Taubert G; Bilek K
Zentralbl Gynakol; 1994; 116(11):609-13. PubMed ID: 7871910
[TBL] [Abstract][Full Text] [Related]
34. Virulence factors in endometrial cancer.
Gusberg SB
Cancer; 1993 Feb; 71(4 Suppl):1464-6. PubMed ID: 8431881
[TBL] [Abstract][Full Text] [Related]
35. Papillary squamous cell carcinoma of the uterine cervix: a clinicopathologic study of nine cases.
Randall ME; Andersen WA; Mills SE; Kim JA
Int J Gynecol Pathol; 1986; 5(1):1-10. PubMed ID: 3957549
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: comparison with other clinical-pathologic parameters.
Susini T; Rapi S; Savino L; Boddi V; Berti P; Massi G
Am J Obstet Gynecol; 1994 Feb; 170(2):527-34. PubMed ID: 8116708
[TBL] [Abstract][Full Text] [Related]
37. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
38. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
Creutzberg CL; van Putten WL; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van den Bergh AC; van de Steen-Banasik E; Beerman H; van Lent M
Lancet; 2000 Apr; 355(9213):1404-11. PubMed ID: 10791524
[TBL] [Abstract][Full Text] [Related]
39. Comparison between clinical and surgical staging for endometrial cancer in Thailand.
Buranawattanachoke S; Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Khunnarong J
Asian Pac J Cancer Prev; 2009; 10(4):685-90. PubMed ID: 19827895
[TBL] [Abstract][Full Text] [Related]
40. Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence.
Greven KM; Lanciano RM; Corn B; Case D; Randall ME
Cancer; 1993 Jun; 71(11):3697-702. PubMed ID: 8490920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
